Phase II trial of topotecan administered as a 21-day continuous infusion in previously untreated patients with stage IIIB and IV non-small-cell lung cancer (Q33503990)
scientific article
Language:
(P31) (Q13442814)
(P304) 438-441
(P433) 5
(P478) 21
(P577) Thursday, October 1, 1998
(P921) (Q42824440)
(P1433) (Q2886177)
(P1476) "Phase II trial of topotecan administered as a 21-day continuous infusion in previously untreated patients with stage IIIB and IV non-small-cell lung cancer" (language: en)
(P2093) Kindler HL
Kris MG
Smith IE
Miller VA
Grant SC
Krebs JB
Ross GA
Slevin ML
other details
description scientific article

External Links